The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Fuselieve 1 mg/g + 5 mg/g Gel for Dogs

1,5 milligram(s)/gram Gel

Norbrook Laboratories (Ireland) LimitedVPA22664/147/001

Main Information

Trade NameFuselieve 1 mg/g + 5 mg/g Gel for Dogs
Active SubstancesBetamethasone valerate
Fusidic acid hemihydrate
Strength1,5 milligram(s)/gram
Dosage FormGel
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/147/001

Group Information

ATC CodeQD07CC01 betamethasone and antibiotics
Therapeutic ClassCorticosteroid


Licence Issued15/03/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back